Indevus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
http://www.companiesandmarkets.com/Summary-Company-Profile/indevus-pharmaceuticals,-inc.-pharmaceuticals-healthcare-deals-and-alliances-profile-164396.asp
- Market - Healthcare and Medical
- Published Date - 01/07/2009
- Report Type - Company Profile
- Country - Global
- Number of Pages - 21
- Electronic - £158.00
- Site Licence - £316.00
- Corporate Licence - £473.00
Report Summary
Indevus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Indevus Pharmaceuticals, Inc. (Indevus), a specialty pharmaceutical company, is engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The company has four major product namely SANCTURA and SANCTURA XR for overactive bladder (OAB); VANTAS for advanced prostate cancer; SUPPRELIN LA for central precocious puberty (CPP), and DELATESTRYL for the treatment of hypogonadism. Its pipeline product includes VALSTAR for bladder cancer, NEBIDO for hypogonadism, PRO 2000 for the prevention of infection by human immunodeficiency virus (HIV) and other sexually transmitted diseases.
The Indevus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Table of Contents
Table Of Contents
Table Of Contents 2
List of Tables 3
List of Figures 3
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 7
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
Indevus Acquires Delatestryl From Savient Pharmaceuticals 9
Acquisition 10
Endo Pharmaceuticals Acquires Indevus Pharmaceuticals 10
Indevus Pharmaceutical Completes Private Placement Of $105 Million 12
Equity Offering 13
Indevus Pharmaceuticals Completes Public Offering Of $37.43 Million 13
Merger 14
Indevus Pharmaceuticals Merges With Valera Pharmaceuticals 14
Partnerships 15
Alkermes Terminates Agreement With Indevus 15
Indevus Enters Into A Licensing Agreement With Madaus 16
Indevus Entered Into Licensing Agreement With Schering 17
Indevus Enters Into Co-Marketing Agreement With Pliva 18
Key Competitors 19
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About Global Markets Direct 21
Contact Us 21
Disclaimer 21
List of Tables
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
Indevus Pharmaceuticals, Inc., Deals By Sector, 2004 to YTD 2009 7
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
Indevus Acquires Delatestryl From Savient Pharmaceuticals 9
Endo Pharmaceuticals Acquires Indevus Pharmaceuticals 10
Indevus Pharmaceutical Completes Private Placement Of $105 Million 12
Indevus Pharmaceuticals Completes Public Offering Of $37.43 Million 13
Indevus Pharmaceuticals Merges With Valera Pharmaceuticals 14
Alkermes Terminates Agreement With Indevus 15
Indevus Enters Into A Licensing Agreement With Madaus 16
Indevus Entered Into Licensing Agreement With Schering 17
Indevus Enters Into Co-Marketing Agreement With Pliva 18
Indevus Pharmaceuticals, Inc., Key Employees 19
Indevus Pharmaceuticals, Inc., Subsidiaries 20
List of Figures
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 5
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
Indevus Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 7